Pediatric germ cell tumors

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Germ cell tumors are relatively rare tumors in childhood which often present with very large tumors in both gonadal and extragonadal locations. Extragonadal tumors are more common in neonates and infants, whereas gonadal sites predominate in childhood and adolescence. Management consists of surgical resection for localized disease, chemotherapy for residual or metastatic disease, and neoadjuvant chemotherapy and delayed surgical excision for unresectable lesions. The survival for children with germ cell tumors has improved significantly over the past 2 decades with the development of platinum-based chemotherapy. Mature and immature teratomas at any site, and completely resected (Stage 1) malignant gonadal and extragonadal tumors, are treated with surgical excision and observation. Malignant lesions with microscopic residual, lymph node disease, or metasiatic disease receive platinum-based chemotherapy. Current survival for low-stage (Stages I and II) gonadal sites approaches 100% and survival for higher stage (Stages III and IV) gonadal sites is approximately 95%. Survival for extragonadal lesions is approximately 90% for Stages I and II and 75% for Stages III and IV.

Original languageEnglish
Pages (from-to)144-158
Number of pages15
JournalSeminars in Surgical Oncology
Volume16
Issue number2
DOIs
StatePublished - Mar 1999

Fingerprint

Germ Cell and Embryonal Neoplasms
Pediatrics
Drug Therapy
Teratoma
Platinum
Neoplasms
Lymph Nodes
Observation
Newborn Infant

Keywords

  • Adjuvant chemotherapy
  • Adolescence
  • Adult
  • Alpha-fetoproteins
  • Antineoplastic agents
  • Biological tumor markers
  • Child
  • Choriocarcinoma
  • Chorionic gonadotropins
  • Combined antineoplastic agents
  • Cryptorchidism
  • Endodermal sinus tumor
  • Germ cell and embryonal neoplasms
  • Germinoma
  • Gonadal tissue neoplasms
  • Infant
  • Lactate dehydrogenase isoenzymes
  • Lymph nodes
  • Neoplasm metastasis
  • Neoplasm staging
  • Newborn infant
  • Oophorectomy
  • Orchiectomy
  • Ovarian neoplasms
  • Preschool child
  • Seminoma
  • Survival rate
  • Teratoma
  • Testicular neoplasms

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Pediatric germ cell tumors. / Rescorla, Frederick.

In: Seminars in Surgical Oncology, Vol. 16, No. 2, 03.1999, p. 144-158.

Research output: Contribution to journalArticle

@article{9f1e68e195f6436183bc48b4e5e9ce68,
title = "Pediatric germ cell tumors",
abstract = "Germ cell tumors are relatively rare tumors in childhood which often present with very large tumors in both gonadal and extragonadal locations. Extragonadal tumors are more common in neonates and infants, whereas gonadal sites predominate in childhood and adolescence. Management consists of surgical resection for localized disease, chemotherapy for residual or metastatic disease, and neoadjuvant chemotherapy and delayed surgical excision for unresectable lesions. The survival for children with germ cell tumors has improved significantly over the past 2 decades with the development of platinum-based chemotherapy. Mature and immature teratomas at any site, and completely resected (Stage 1) malignant gonadal and extragonadal tumors, are treated with surgical excision and observation. Malignant lesions with microscopic residual, lymph node disease, or metasiatic disease receive platinum-based chemotherapy. Current survival for low-stage (Stages I and II) gonadal sites approaches 100{\%} and survival for higher stage (Stages III and IV) gonadal sites is approximately 95{\%}. Survival for extragonadal lesions is approximately 90{\%} for Stages I and II and 75{\%} for Stages III and IV.",
keywords = "Adjuvant chemotherapy, Adolescence, Adult, Alpha-fetoproteins, Antineoplastic agents, Biological tumor markers, Child, Choriocarcinoma, Chorionic gonadotropins, Combined antineoplastic agents, Cryptorchidism, Endodermal sinus tumor, Germ cell and embryonal neoplasms, Germinoma, Gonadal tissue neoplasms, Infant, Lactate dehydrogenase isoenzymes, Lymph nodes, Neoplasm metastasis, Neoplasm staging, Newborn infant, Oophorectomy, Orchiectomy, Ovarian neoplasms, Preschool child, Seminoma, Survival rate, Teratoma, Testicular neoplasms",
author = "Frederick Rescorla",
year = "1999",
month = "3",
doi = "10.1002/(SICI)1098-2388(199903)16:2<144::AID-SSU6>3.0.CO;2-M",
language = "English",
volume = "16",
pages = "144--158",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Pediatric germ cell tumors

AU - Rescorla, Frederick

PY - 1999/3

Y1 - 1999/3

N2 - Germ cell tumors are relatively rare tumors in childhood which often present with very large tumors in both gonadal and extragonadal locations. Extragonadal tumors are more common in neonates and infants, whereas gonadal sites predominate in childhood and adolescence. Management consists of surgical resection for localized disease, chemotherapy for residual or metastatic disease, and neoadjuvant chemotherapy and delayed surgical excision for unresectable lesions. The survival for children with germ cell tumors has improved significantly over the past 2 decades with the development of platinum-based chemotherapy. Mature and immature teratomas at any site, and completely resected (Stage 1) malignant gonadal and extragonadal tumors, are treated with surgical excision and observation. Malignant lesions with microscopic residual, lymph node disease, or metasiatic disease receive platinum-based chemotherapy. Current survival for low-stage (Stages I and II) gonadal sites approaches 100% and survival for higher stage (Stages III and IV) gonadal sites is approximately 95%. Survival for extragonadal lesions is approximately 90% for Stages I and II and 75% for Stages III and IV.

AB - Germ cell tumors are relatively rare tumors in childhood which often present with very large tumors in both gonadal and extragonadal locations. Extragonadal tumors are more common in neonates and infants, whereas gonadal sites predominate in childhood and adolescence. Management consists of surgical resection for localized disease, chemotherapy for residual or metastatic disease, and neoadjuvant chemotherapy and delayed surgical excision for unresectable lesions. The survival for children with germ cell tumors has improved significantly over the past 2 decades with the development of platinum-based chemotherapy. Mature and immature teratomas at any site, and completely resected (Stage 1) malignant gonadal and extragonadal tumors, are treated with surgical excision and observation. Malignant lesions with microscopic residual, lymph node disease, or metasiatic disease receive platinum-based chemotherapy. Current survival for low-stage (Stages I and II) gonadal sites approaches 100% and survival for higher stage (Stages III and IV) gonadal sites is approximately 95%. Survival for extragonadal lesions is approximately 90% for Stages I and II and 75% for Stages III and IV.

KW - Adjuvant chemotherapy

KW - Adolescence

KW - Adult

KW - Alpha-fetoproteins

KW - Antineoplastic agents

KW - Biological tumor markers

KW - Child

KW - Choriocarcinoma

KW - Chorionic gonadotropins

KW - Combined antineoplastic agents

KW - Cryptorchidism

KW - Endodermal sinus tumor

KW - Germ cell and embryonal neoplasms

KW - Germinoma

KW - Gonadal tissue neoplasms

KW - Infant

KW - Lactate dehydrogenase isoenzymes

KW - Lymph nodes

KW - Neoplasm metastasis

KW - Neoplasm staging

KW - Newborn infant

KW - Oophorectomy

KW - Orchiectomy

KW - Ovarian neoplasms

KW - Preschool child

KW - Seminoma

KW - Survival rate

KW - Teratoma

KW - Testicular neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0032939536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032939536&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1098-2388(199903)16:2<144::AID-SSU6>3.0.CO;2-M

DO - 10.1002/(SICI)1098-2388(199903)16:2<144::AID-SSU6>3.0.CO;2-M

M3 - Article

C2 - 9988869

AN - SCOPUS:0032939536

VL - 16

SP - 144

EP - 158

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 2

ER -